132 related articles for article (PubMed ID: 35711825)
1. ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma.
Pan Q; Li F; Ding Y; Huang H; Guo J
J Cancer; 2022; 13(8):2504-2514. PubMed ID: 35711825
[No Abstract] [Full Text] [Related]
2. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
3. ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression.
Chen L; Zhang D; Chen Y; Zhu H; Liu Z; Yu Z; Xie J
Oncol Lett; 2024 Mar; 27(3):96. PubMed ID: 38288041
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
5. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
7. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
8. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.
Zhu J; Chen Q; Zeng L; Gao H; Wu T; He Y; Xu J; Pang J; Peng J; Deng Y; Han Y; Yi W
Front Immunol; 2023; 14():1236806. PubMed ID: 37901236
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
11. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.
Ha M; Jeong H; Roh JS; Lee B; Han ME; Oh SO; Sohn DH; Kim YH
Urol Oncol; 2019 Oct; 37(10):735-741. PubMed ID: 31377166
[TBL] [Abstract][Full Text] [Related]
12. PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma.
Wang K; Ruan H; Song Z; Cao Q; Bao L; Liu D; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Yang H; Chen K; Zhang X
Urol Oncol; 2018 Jul; 36(7):343.e9-343.e19. PubMed ID: 29773494
[TBL] [Abstract][Full Text] [Related]
13. TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.
Xiao W; Wang X; Wang T; Xing J
Cancer Manag Res; 2018; 10():5951-5964. PubMed ID: 30538545
[TBL] [Abstract][Full Text] [Related]
14. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Sui Y; Lu K; Fu L
PeerJ; 2021; 9():e11272. PubMed ID: 33976979
[TBL] [Abstract][Full Text] [Related]
15. Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Meng X; Yuan H; Li W; Xiao W; Zhang X
Int J Gen Med; 2021; 14():5255-5267. PubMed ID: 34522125
[TBL] [Abstract][Full Text] [Related]
16.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
18. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
19. High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma.
Zhou J; Zhu Y; Liu Y; Niu P; Chen H; Deng J; Shi D
Transl Androl Urol; 2020 Aug; 9(4):1650-1660. PubMed ID: 32944526
[TBL] [Abstract][Full Text] [Related]
20. High SAA1 Expression Predicts Advanced Tumors in Renal Cancer.
Li S; Cheng Y; Cheng G; Xu T; Ye Y; Miu Q; Cao Q; Yang X; Ruan H; Zhang X
Front Oncol; 2021; 11():649761. PubMed ID: 34084746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
